NCT03534804 2024-11-26
PemCab
University of Utah
Phase 2 Completed
Clinical Trials
3 trialsNCT02795156 2023-12-05
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01688999 2022-10-18
Cabozantinib for Advanced Urothelial Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed